Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Screening for prostate cancer: arguments "against"].

P Perrin1

  • 1Centre Hospitalier Lyon Sud, Chemin Grand Revoyet, 69495 Pierre-Bénite, France. paul.perrin@chu-lyon.fr

Annales D'Urologie
|May 20, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Supramolecular microgels for Pickering emulsion stabilization in the limited coalescence regime: The key role of microgel structure.

Journal of colloid and interface science·2026
Same author

Skull Vibration Induced afternystagmus: A new clinical indicator of superior canal dehiscence.

European annals of otorhinolaryngology, head and neck diseases·2025
Same author

Longevity of immediate rehabilitation with direct metal-wire reinforced composite fixed partial dentures.

Dental materials : official publication of the Academy of Dental Materials·2022
Same author

Cytokine release syndrome-associated encephalopathy in patients with COVID-19.

European journal of neurology·2020
Same author

Longevity of immediate rehabilitation with direct fiber reinforced composite fixed partial dentures after up to 9 years.

Journal of dentistry·2020
Same author

The skull vibration-induced nystagmus test: A useful vestibular screening test in children with hearing loss.

European annals of otorhinolaryngology, head and neck diseases·2020

Prostate cancer screening is controversial. While proponents cite early diagnosis benefits, evidence for reduced mortality from screening is currently low, making it not routinely recommended.

Area of Science:

  • Urology
  • Oncology
  • Preventive Medicine

Context:

  • Prostate cancer screening, particularly using the prostate-specific antigen (PSA) assay, remains a subject of significant debate.
  • Arguments supporting screening often rely on observational data suggesting early detection leads to less aggressive treatment.
  • The lack of robust randomized controlled trials (RCTs) has hindered definitive conclusions regarding screening's efficacy.

Purpose:

  • To evaluate the controversial role of prostate cancer screening in reducing mortality.
  • To assess the evidence supporting the benefits of early diagnosis through screening versus the risks and uncertainties.
  • To provide a recommendation on the necessity of prostate cancer screening based on current data.

Summary:

  • Current evidence supporting prostate cancer screening is largely based on longitudinal cohort studies lacking control groups.

Related Experiment Videos

  • Randomized studies are underway to definitively assess the correlation between screening and mortality reduction, with results expected in 3-4 years.
  • Analysis of available parameters indicates a minimal reduction in cancer mortality attributable to screening, leading to its non-recommendation by health institutions.

    • Impact:

    • The validity and effectiveness of prostate cancer screening remain uncertain pending results from ongoing randomized trials.
    • Current data suggest that the mortality reduction benefit from screening is low.
    • The recommended approach balances vigilance and over-intervention, advocating for patient-initiated testing rather than routine screening.